MiSalud Health
Series A in 2024
MiSalud is a health and wellness platform that focuses on delivering personalized preventative services and traditional healthcare tailored to the Latino community. The company provides a virtual care platform that connects users with Spanish-speaking physicians and experienced medical practitioners, ensuring culturally relevant care. Services offered include access to customized health plans, support groups, psychological support, and comprehensive wellness content in Spanish. MiSalud aims to enhance employee health and wellbeing while delivering measurable results for employers and employees alike, making healthcare more convenient and accessible.
Eleos Health
Series B in 2023
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.
Pillyze develops a nutrition analysis platform designed to help individuals manage their intake of healthy functional foods and pharmaceuticals. The platform offers tools for analyzing, searching, and managing food options tailored to individual health needs, promoting healthier lifestyle choices. By focusing on the intersection of nutrition and wellness, Pillyze aims to empower users to make informed dietary decisions that support their overall health.
Affect Therapeutics
Series A in 2023
Affect Therapeutics operates a digital treatment platform designed to address drug and alcohol addiction through a mobile application. The company offers an integrated program for various substance use disorders, utilizing contingency management and reward systems to engage users and promote retention. By providing financial incentives, the platform encourages patients to adopt healthier behaviors and establish new habits, ultimately aiming to improve outcomes for individuals seeking to overcome addiction.
Calibrate
Convertible Note in 2022
Calibrate is a digital health company focused on improving metabolic health to achieve sustainable weight loss. Founded in 2020 and based in New York, Calibrate offers a virtual weight management program that integrates FDA-approved metabolic medications with personalized coaching and a comprehensive curriculum designed by experts in obesity and nutrition. The platform emphasizes behavior change and provides one-on-one virtual sessions with healthcare professionals, aiming to foster lasting habits for its users. Calibrate's approach combines telemedicine with a value-based pricing model, ensuring effective obesity treatment outcomes while facilitating the necessary physiological changes for improved health.
Brave Health
Series C in 2022
Brave Health operates a virtual clinic that provides telehealth services focused on mental health and addiction treatment. Established in 2017 in Miami, Florida, the company specializes in behavioral health, offering a range of services including counseling, therapy, psychiatry, and medication management, which encompasses medication-assisted treatment. This telehealth approach allows patients to receive comprehensive care for various conditions related to mental health and substance use disorders, facilitating greater access to necessary treatment.
Malama
Pre Seed Round in 2022
Malama is a developer of a personalized support platform aimed at improving pregnancy-related health outcomes, particularly for individuals managing diabetes during pregnancy. The platform offers tools for tracking glucose levels and meal intake, helping users identify dietary triggers and trends. Additionally, it provides access to one-on-one coaching, facilitating the optimization of health throughout pregnancy. By delivering actionable insights, Malama empowers patients to enhance their health and well-being during this critical period.
Pery
Pre Seed Round in 2022
Pery is an innovative digital health startup on a mission to build a better, more comprehensive and accessible care model to improve the experience of care for children with ADHD and their families. Our aim is to provide accessible, evidence-based treatment to children and families, empowering parents and children to develop the knowledge and skills they need to thrive. Come be a part of a collaborative, multidisciplinary clinical care team committed to transforming mental health care for children with ADHD and their families.
Terra API
Seed Round in 2021
Terra API specializes in facilitating the seamless transfer of health data between various applications and devices. The company provides an online application programming interface (API) that enables developers to connect easily with health apps, wearables, sensors, and blood laboratories. By utilizing standard protocols for data exchange, Terra API allows applications to accept requests and return responses in commonly used formats, supporting efficient communication across diverse fitness tracking devices. This integration empowers users to share and access their health and fitness data from multiple sources, enhancing the overall user experience in health management.
Big Health
Series B in 2020
Big Health is a digital therapeutics company based in London, United Kingdom, specializing in sleep improvement solutions. It offers a digital healthcare portal that provides fully automated and personalized behavioral programs aimed at addressing mental health issues, particularly sleep disorders. The flagship application, Sleepio, utilizes Cognitive Behavioral Therapy techniques to tailor interventions to individual users' needs, helping them effectively manage and overcome their sleep-related challenges. By consulting with medical professionals, Big Health ensures that its programs are both evidence-based and user-friendly, promoting better sleep and overall mental well-being.
DayTwo Ltd. is a precision nutrition company headquartered in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome insights to improve health outcomes and prevent diseases such as diabetes, prediabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo employs microbiome sequencing to create personalized dietary recommendations, known as Food Prescriptions™, tailored to individual responses to food. This approach helps manage blood sugar levels, enhance energy, control hunger, and promote weight loss. DayTwo delivers its services through a digital platform and mobile application, enabling users to track their progress and communicate with certified diabetes care specialists and registered dietitians. By emphasizing personalized nutrition based on scientific research, DayTwo aims to empower patients to lead healthier lives through informed dietary choices.
DayTwo Ltd. is a precision nutrition company headquartered in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome insights to improve health outcomes and prevent diseases such as diabetes, prediabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo employs microbiome sequencing to create personalized dietary recommendations, known as Food Prescriptions™, tailored to individual responses to food. This approach helps manage blood sugar levels, enhance energy, control hunger, and promote weight loss. DayTwo delivers its services through a digital platform and mobile application, enabling users to track their progress and communicate with certified diabetes care specialists and registered dietitians. By emphasizing personalized nutrition based on scientific research, DayTwo aims to empower patients to lead healthier lives through informed dietary choices.
HealthifyMe
Series B in 2018
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.
HealthifyMe
Series B in 2018
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
BioBeats
Seed Round in 2015
BioBeats is a London-based company that develops artificial intelligence products aimed at addressing global mental health issues. As mental and substance use disorders account for a significant portion of the global disease burden, BioBeats seeks to provide innovative solutions through its psychological wellness application. This app calculates a baseline wellbeing score and offers personalized support by integrating biometric data from biosensors and wearable devices. By analyzing both physiological and psychological indicators, the application helps users identify harmful patterns and understand their responses to stress, ultimately aiming to enhance overall mental wellbeing. With a foundation built on 15 years of research, including collaborations with the University of Oxford, BioBeats leverages real-time data to improve psychological therapy and facilitate early intervention for mental health disorders. The company was established in 2012 and has been committed to advancing mental health support through technology.
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
WellTheory is a virtual care platform providing autoimmune and inflammatory conditions care services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.